ESHRE supports the Male Reproductive Health Initiative

The Male Reproductive Health Initiative (MRHI) is a global collaboration dedicated to advancing the science and practice of male reproductive medicine. The MRHI accomplishes its mission by promoting and contributing to high quality research in both basic and clinical science, forging collaborative relationships with professional societies to contribute to a mission of education, and through advocacy of MRHI to all stakeholders including patient support groups, funding agencies, non-for-profit organizations, industry, and the public.

ESHRE's virtual Annual Meeting

Thank you to all participants who joined us during these four congress days! We hope you all enjoyed the congress and look forward to seeing you all next year in Paris!
Until then #staysafe
You can view the list of this year's award winning presentations here. The scientific and corporate presentations of this annual meeting will stay available to registered participants until the end of this year. Registration is free for members. Participants can still visit the virtual exhibition, view e-posters, continue discussions in the forum and print their certificate of attendance.

Paper on Ethics of expanded carrier screening open for stakeholder review

The ESHRE Ethics Committee Writing Group has finalized the draft of a paper entitled: "The Ethics of Preconception Expanded Carrier Screening in Applicants of Medically Assisted Reproduction"
The document has been published on the ESHRE website and will be open for stakeholder review until 17 August 2020.

Breast cancer drug, olaparib, depletes store of immature eggs in mouse ovaries Fertility preservation counselling should be considered for young women before treatment with the drug, say researchers

Human Reproduction Press Release
Australian researchers have shown for the first time that a new drug used to treat breast cancer patients damages the store of immature eggs in the ovaries of mice.